14. Pharmaceutical Technology. “Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications.” 2025. Details warning letters related to promotional communications.
15. Kim, Jong-Hee, et al. “Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.” New England Journal of Medicine 381 (2019): 1644–1652. Describes the development and administration of milasen for Batten disease.
16. Boston Children’s Hospital. “Custom Genetic Treatments and the Future of N-of-1 Medicine.” 2022. Discusses development costs and logistical challenges for individualized antisense therapies.